Advances in Immunology: Primary immunodeficiency diseases due to defects in lymphocytes

New England Journal of Medicine

Volumn 343, Issue 18, 2000, Pages 1313-

  Buckley, Rebecca H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CARRIER PROTEIN; CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; TRANSCRIPTION FACTOR; LEUKOCYTE ANTIGEN;

ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; B LYMPHOCYTE; CANCER RISK; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; METABOLIC DISORDER; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; WISKOTT ALDRICH SYNDROME; CLASSIFICATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MUTATION;

ANTIGENS, CD; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTES; MAJOR HISTOCOMPATIBILITY COMPLEX; MUTATION; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 0034597508     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200011023431806     Document Type: Review

References (105)

1. Essentielle Lymphocytophtose: Ein neues Krankheitsbild aus der Sauglingspathologie
2. Agammaglobulinemia
3. Primary immunodeficiency diseases report of an IUIS Scientific Committee
4. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia
5. X-linked agammaglobulinemia: An analysis of 96 patients
6. Ureaplasma urealyticum chronic osteomyelitis in a patient with hypogammaglobulinemia
7. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
8. Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants
9. Blood leukocyte values: Man
10. Bone marrow transplantation in primary immunodeficiency
11. A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage
12. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia
13. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia
14. Mutations in Igalpha (CD79a) result in a complete block in B-cell development
15. An essential role for BLNK in human B cell development
16. Gene deletions in the human immunoglobulin heavy chain constant region locus: Molecular and immunological analysis
17. Immunodeficiency with hyper-IgM (HIM)
18. Clinical spectrum of X-linked hyper-IgM syndrome
19. Mapping of the X-linked form of hyper-IgM syndrome (HIGMI) to Xq26 by close linkage to HPRT
20. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome
21. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM
22. The CD40 ligand, gp39, is defective in activated T ceils from patients with X-linked hyper-IgM syndrome
23. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
24. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
25. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM: Abortive germinal center cell reaction and severe depletion of follicular dendritic cells
26. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40
27. CD40Lbase: A database of CD40L gene mutations causing X4inked hyper-IgM syndrome
28. Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome
29. Prenatal diagnosis of X-linked hyper-IgM syndrome
30. Immunodeficiency with hyperimmunoglobulinemia M in two female patients is not associated with abnormalities of CD40 or CD40 ligand expression
31. Hyper IgM syndrome associated with defective CD40-mediated B cell activation
32. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome
33. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases
34. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
35. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages
36. Agammaglobulinemia, neutropenia, fevers and abdominal pain
37. Neutropenia in X-linked agammaglobulinemia
38. BTKbase, mutation database for X-linked agammaglobulinemia (XLA)
39. Primary immunodeficiency caused by mutations in the gene encoding the CD3-γ subunit of the T-lymphocyte receptor
40. Independent mutations of the human CD3-gene resulting in a T cell receptor/CD3 complex immunodeficiency
41. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1
42. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans
43. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
44. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency
45. Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor
46. Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor
47. Arypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells
48. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
49. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor
50. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
51. Defective expression of p56lck in an infant with severe combined immunodeficiency
52. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase
53. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase
54. Essential role for ZAP-70 in both positive and negative selection of thymocytes
55. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
56. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
57. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3' kinase
58. RAG mutations in human B-cell-negative SCID
59. Partial V(D)J recombination activity leads to Omenn syndrome
60. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome
61. T-cell receptor analysis in Omenn's syndrome: Evidence for defects in gene rearrangement and assembly
62. The lymph node pathology of Omenn's syndrome
63. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease
64. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency
65. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase
66. PEG-ADA replacement therapy for adenosine deaminase deficiency: An update after 8.5 years
67. Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcome
68. Human T cell repertoire generation in the absence of MHC class II expression results in a circulating CD4+CD8- population with altered physicochemical properties of complementarity-determining region 3
69. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
70. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)
71. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
72. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency
73. Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome
74. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1
75. Homozygous human TAP peptide transporter mutation in HLA class deficiency
76. A case of primary Immunodeficiency due to a defect of the major histocompatibility gene complex dass I processing and presentation pathway
77. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis
78. Dependence of peptide binding by MHC class I molecules on their interaction with TAP
79. X-linked lymphoproliferative syndrome
80. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease
81. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
82. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
83. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
84. Aberrant patterns of immunoglobulin levels in Wiskott-Aldrich syndrome
85. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
86. Wiskott-Aldrich syndrome prorein, a novel effector for the GTPase CDC42HS, is implicated in actin polymerization
87. WASPbase: A database of WAS- and XLT-causing mutations
88. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene
89. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at the DXS6940, adjacent to the disease gene
90. Two sisters with clinical diagnosis of Wiskott-Aldrich syndrome: Is the condition in the family autosomal recessive?
91. Wiskott-Aldrich syndrome: Report of an autosomal dominant variant
92. X-linked Wiskott-Aldrich syndrome in a girl
93. Allogeneic bone marrow transplantation (BMT) for Wiskott Aldrich syndrome (WAS): Comparison of outcomes by donor type
94. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: Long-term follow-up of 62 cases
95. Ataxia-telangiectasia: An interdisciplinary approach to pathogenesis
96. Leukemia and lymphoma in ataxia telangiectasia
97. Transfusion-associated graft-versus-host disease in ataxia telangiectasia
98. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation
99. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
100. DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product
101. Dual roles of ATM in the cellular response to radiation and in cell growth control Genes Dev
102. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection
103. Individuals with IgA deficiency and common variable immunodeficiency share complex polymorphisms of major histocompatibility complex class III genes
104. Genetic linkage of hyper-IgE syndrome to chromosome 4